Top compounds associated with response to CTD-2331H12.8


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.11 0.006
mRNA decitabine CTRPv2 pan-cancer AAC 0.078 0.007
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.097 0.01
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.01
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.087 0.01
mRNA simvastatin CTRPv2 pan-cancer AAC -0.1 0.01
mRNA Compound 1541A CTRPv2 pan-cancer AAC 0.099 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
Download CSV